This NDC is on FDA's drug shortage list (posted Jun 6, 2018)

Product Information

KETOROLAC 60 MG/2 ML VIAL is a generic product labeled by Fosun Pharma USA Inc., priced at $0.6167 per ML under NDC 72266011925. Its NADAC has been published 354 times since Feb 5, 2020.

FDA first approved this application on Nov 1, 2016. Its Orange Book therapeutic-equivalence code is AP.

KETOROLAC 60 MG/2 ML VIAL

ketorolac tromethamine
$0.6167per ML

Strength

30 mg/mL

NDC

72266011925

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR

Effective Date

10/21/2026

Active Ingredients

KETOROLAC TROMETHAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA204216

FDA Approved

11/1/2016

TE Code

AP

On Market Since

6/23/2023

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitor
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for KETOROLAC 60 MG/2 ML VIAL has been published 354 times since Feb 5, 2020, and over the history we have for it it has declined 46.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6167 per ML
All-time high$1.1575 (Mar 11, 2020)
All-time low$0.4543 (Feb 18, 2026)
52-week high$0.6167
52-week low$0.4543
Median price$0.7592
Average price$0.7641
Largest weekly change+26.3% (May 18, 2022)
Weeks tracked354
Tracking sinceFeb 5, 2020

Price History

1W

0.0%

1M

+11.6%

3M

+23.8%

6M

+20.0%

1Y

+13.4%

3Y

-13.4%

5Y

-31.3%

All

-46.5%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of KETOROLAC 60 MG/2 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 60 MG/2 ML VIAL, manufactured by Fosun Pharma USA Inc., is $0.6167 per ML (NDC 72266011925), effective Nov 11, 2026.

How has the price of KETOROLAC 60 MG/2 ML VIAL changed over time?

Over the history we have for it, the NADAC for KETOROLAC 60 MG/2 ML VIAL has declined 46.5%. It has been tracked across 354 weekly CMS publications since Feb 5, 2020.

What are the highest and lowest recorded NADAC prices for KETOROLAC 60 MG/2 ML VIAL?

Since Feb 5, 2020, the NADAC for KETOROLAC 60 MG/2 ML VIAL has ranged from a low of $0.4543 (Feb 18, 2026) to a high of $1.1575 (Mar 11, 2020), with a median of $0.7592 per ML.

Are there cheaper alternatives to KETOROLAC 60 MG/2 ML VIAL?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as KETOROLAC 60 MG/2 ML VIAL in a comparable dosage form, but none are currently priced below it.

Who manufactures KETOROLAC 60 MG/2 ML VIAL?

KETOROLAC 60 MG/2 ML VIAL (NDC 72266011925) is labeled by Fosun Pharma USA Inc., and CMS classifies it as a generic product.

Is KETOROLAC 60 MG/2 ML VIAL in shortage?

Yes — NDC 72266011925 is currently listed in FDA's drug shortage database (posted Jun 6, 2018).